English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

With the reform of medical system, China’s pharmaceutical industry has entered a period of adjustment and transformation with steady development. The comprehensive performance evaluation of pharmaceutical companies is conducive to understanding the overall operation and development potential of the pharmaceutical industry in China, and has reference significance for the decision-making of all stakeholders. Based on the balanced scorecard, this paper designs a comprehensive performance evaluation system at the financial and non-financial levels, using scientific and effective evaluation methods to analyse the performance of pharmaceutical industry companies, which will play an important role in improving the comprehensive performance evaluation of pharmaceutical industry companies.

Research on Performance Evaluation System of Innovative Pharmaceutical Enterprises Based on Balanced Scorecard——Taking CCS1 WuXi AppTec as an Example2